E-LIB Suche - Ergebnisse für: Panés, J.

1

DOP52 Guselkumab improves symptoms of fatigue in patients w..:

Dignass, A ; Panés, J ; Rubin, D T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i166-i167 , 2024

2

P026 Differential effects of tofacitinib on macrophage acti..:

Melón-Ardanaz, E ; Veny, M ; Corraliza, A M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i280-i281 , 2024

Link: https://doi.org/10.1093/..

3

OP18 Efficacy and safety of darvadstrocel treatment in pati..:

Serclova, Z ; Garcia-Olmo, D ; Chen, S T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i34-i35 , 2024

Link: https://doi.org/10.1093/..

4

DOP66 INSPIRE: Preliminary data from an observational post-..:

Fathallah, N ; Zmora, O ; Baumgart, D C...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i192-i194 , 2024

Link: https://doi.org/10.1093/..

5

P954 Cumulative response to guselkumab through week 24 of i..:

Rubin, D ; Sands, B ; Lichtenstein, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1732-i1733 , 2024

Link: https://doi.org/10.1093/..

6

P862 Effects of induction and maintenance therapy with risa..:

Panés, J ; Loftus Jr., E V ; Armuzzi, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1596-i1597 , 2024

Link: https://doi.org/10.1093/..

7

DOP49 Guselkumab improves health-related quality of life as..:

Panés, J ; Dignass, A ; Lichtenstein, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i161-i162 , 2024

Link: https://doi.org/10.1093/..

8

DOP54 Guselkumab and golimumab combination induction therap..:

Richards, D ; Vetter, M ; Germinaro, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i171-i172 , 2024

Link: https://doi.org/10.1093/..

9

P1010 Guselkumab improves abdominal pain and bowel urgency ..:

Rubin, D ; Panés, J ; Feagan, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1825-i1826 , 2024

Link: https://doi.org/10.1093/..

10

DOP76 Individual and comprehensive symptom resolution after..:

Tinoco da Silva Torres, J ; Panés, J ; Siegel, C A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i214-i215 , 2024

Link: https://doi.org/10.1093/..

11

OP20 The effects of upadacitinib on ulcerative colitis symp..:

D'Haens, G ; Tran, J ; Danese, S...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i27-i29 , 2023

Link: https://doi.org/10.1093/..

12

Observational study on the therapeutic management and econo..:

Villani, A. P. ; Quiles Tsimaratos, N. ; Crochard, A....
Journal of Market Access & Health Policy. 11 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

13

DOP41 Achievement of corticosteroid-free clinical endpoints..:

Sands, B E ; Rubin, D T ; Panés, J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i106-i107 , 2023

Link: https://doi.org/10.1093/..

14

P786 Induction of endoscopic response, remission and ulcer-..:

Panés, J ; Louis, E ; Bossuyt, P...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i919-i920 , 2023

Link: https://doi.org/10.1093/..

15

P582 Efficacy of etrasimod at week 52 among subjects who re..:

Vermeire, S ; Sands, B E ; Dubinsky, M C...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i709-i711 , 2023

Link: https://doi.org/10.1093/..